| Polen, Tom (Becton Dickinson 201010 President BD Diagnostics – Diagnostic Systems) |
President/Director/Head Business Group/Unit/Division |
Becton, Dickinson (Group) |
United States (USA) |
| Poli, Sonia (Addex 201501 CSO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Addex (Group) |
Switzerland |
| Polifke, Tobias (Candor Bioscience 201310 Managing Partner) |
Managing Director |
Candor Bioscience GmbH |
Germany |
| Pollack, Leonhard (Olink Proteomics 201605– Scientific Sales Specialist before Schauenburg/Markes + Nonlinear Dynamics) |
Sales Manager / Marketing Manager |
Olink (Group) |
Sweden |
| Pollano, Federico (Rentschler 201803– SVP BusDev before Polpharma Biologics + Richter-Helm + BioGeneriX) |
Business Development Manager / Strategy Manager |
Rentschler (Group) |
Germany |
| Pollentier, Stephane (Boehringer 201802 Therapeutic Area Head Medicine CNS) |
n. a. |
Boehringer Ingelheim (Group) |
Germany |
| Polymeropoulos, Mihal H. (Vanda Pharmaceuticals 200211– founder + CEO before Novartis AG) |
Chief Executive Officer (CEO) |
Vanda Pharmaceuticals (Group) |
United States (USA) |
| Polyntsev, Dmitry (Astra Biotech GmbH 201005 Managing Director) |
Managing Director |
Astra Biotech GmbH |
Germany |
| Polywka, Mario (Evotec 2019– Supervisory Board Member before 201201–201812 COO RETIRED 12/18) |
Supervisory Board Member |
Evotec (Group) |
Germany |
| Pomerantz, Roger (Flagship Ventures 2014– + Seres Therapeutics 201406–CEO before Merck (US)) |
Partner (venture partner) |
Flagship Pioneering |
United States (USA) |
| Pommerening, Ulf (EBS Technologies 201508 CEO) |
Managing Director |
EBS Technologies GmbH |
Germany |
| Pomrehn, Anja (MorphoSys 202010 SVP) |
Public Relations Manager / Investor Relations Manager |
MorphoSys (Group) |
Germany |
| Ponce de Leon, Veronica (Genohm 201603– VP US Branch) |
Sales Manager / Marketing Manager |
Agilent (Group) |
United States (USA) |
| Poonawalla, Cyrus (Poonawalla Group 201307 Chairman + Founder) |
Board member |
Poonawalla (Group) |
India |
| Popoff, Marine (Hookipa Biotech 201704 Communcations Analyst) |
Public Relations Manager / Investor Relations Manager |
Hookipa (Group) |
Austria |
| Popov, Dmitry (Russia (govt) 201203 Managing Partner at Maxwell Biotech Venture Fund) |
Managing Partner (investment firm) |
Russia (govt) |
Russian Federation |
| Popova, Maria (Sanochemia 201104 Managing Director of Sanochemia Diagnostics Deutschland GmbH) |
Managing Director |
Sanochemia (Group) |
Germany |
| Popp, Elisabeth (Biophotonics Diagnostics GmbH 201606– Managing Director) |
Managing Director |
Biophotonics Diagnostics GmbH |
Germany |
| Porter, Mark (Qiagen Instruments 200705) |
n. a. |
Qiagen (Group) |
Switzerland |
| Porter, Richard (Corlieve 201911– CEO + Co-Founder before Therachon + Roche + Shire + Vernalis + Astra) |
Chief Executive Officer (CEO) |
Corlieve Therapeutics S.A.S. |
France |
| Posch, Andreas (Curetis 201703– Director GEAR + Bio-IT + Managing Director Ares Genetics before Siemens Healthcare) |
Managing Director |
Curetis (Group) |
Austria |
| Posch, Dieter (Hessen (govt) 201105 Wirtschaftsminister) |
Minister |
Hessen (govt region) |
Germany |
| Posch, Johannes (Tecan 200506) |
n. a. |
Tecan (Group) |
Switzerland |
| Posner, Lawrence E. (Bayer Pharma Div 1988–2003 Senior VP retired) |
n. a. |
Bayer (Group) |
Germany |
| Possinger, K. |
n. a. |
Humboldt University Berlin |
Germany |
| Post, James (PHC 202002 President of Epredia) |
President/Director/Head Business Group/Unit/Division |
PHC (Group) |
United States (USA) |
| Potgeter, Martin (Qiagen 201411 VP Business Development) |
Business Development Manager / Strategy Manager |
Qiagen (Group) |
Germany |
| Poth, Harald (Landesbank Baden-Württemberg 201105 Senior Investment Manager LBBW Venture Capital GmbH) |
Investment Manager |
LBBW (Group) |
Germany |
| Poth, Jan (Boehringer 201712 Therapeutic Area Head CNS + Immunology) |
Research & Development Manager |
Boehringer Ingelheim (Group) |
Germany |
| Pott, Andreas (EMA 201101–201111 Acting Executive Director) |
Administrative Officer (personnel) |
EU (govt) |
Netherlands |
| Potter, Myrtle (Roivant 201910 Vant Operating Chair at Roivant Pharma before Genentech + BMS) |
n. a. |
Roivant (Group) |
Switzerland |
| Potthoff, Janes (Futalis GmbH 201111– Managing Director + Co-founder) |
Managing Director |
Futalis GmbH |
Germany |
| Poussot, Bernard (Wyeth Pharmaceuticals 200801 promoted CEO before COO since 200701 joined Wyeth 1986) |
Chief Executive Officer (CEO) |
Pfizer (Group) |
United States (USA) |
| Poustka, Anne-Marie |
n. a. |
Helmholtz-Gemeinschaft (HGF) (Group) |
Germany |
| Powell, Kathryn (Schauenburg 201405 PR + Events Officer) |
public relations / investor relations |
Schauenburg (Group) |
United Kingdom (GB) |
| Powell, Keith (PolyTherics 2006–201105 CEO LEFT 5/11) |
Chief Executive Officer (CEO) |
Abzena (Group) |
United Kingdom (GB) |
| Powell, Mike (Sofinnova 201508 General Partner at Sofinnova Ventures) |
General Partner (venture partner) |
Sofinnova (Group) |
United States (USA) |
| Pragnell, Michael (Syngenta –200707– CEO) |
Chief Executive Officer (CEO) |
Syngenta (Group) |
Switzerland |
| Pranada, Arthur (MVZ Dortmund Dr Eberhard & Partner 201506 Head of Microbiology Lab) |
Laboratory Manager (industry) |
MVZ Dortmund Dr. Eberhard & Partner GbR |
Germany |
| Prante, Gerhard (2002– Consultant before CEO of AgrEvo / Aventis CropScience) |
Consultant (economic/technology) |
Bayer (Group) |
Germany |
| Prantl, Manfred (Alicona 201811 Managing Director) |
Managing Director |
Bruker (Group) |
Austria |
| Prasad, G. V. (Dr. Reddy’s 201206 CEO) |
Chief Executive Officer (CEO) |
Dr. Reddy’s (Group) |
India |
| Prasch, Thomas (Nordrhein-Westfalen (Reg) 201207– Office Head at BIO.NRW before Qiagen GmbH + Henkel KGaA) |
Cluster Manager |
Nordrhein-Westfalen (govt region) |
Germany |
| Prause, Burkhard (Bruker 200804– President of BEST joined 2002 before MPI Tuebingen) |
President/Director/Head Business Group/Unit/Division |
Bruker (Group) |
United States (USA) |
| Prause, Guido (Fraunhofer MEVIS 200901– before MeVis Research) |
n. a. |
Fraunhofer (Group) |
Germany |
| Prechel, Helmut (Biozym Scientific 200512) |
n. a. |
Biozym (DE) (Group) |
Germany |
| Precht, Engelbert (Medigenomix 200809 and BIO Deutschland) |
Managing Director |
Eurofins (Group) |
Germany |
| Prehn, Guido (DPE Deusche Private Equity 201706 Partner) |
Partner (venture partner) |
DPE Deutsche Private Equity GmbH |
Germany |
| Prescher, Horst (SialoTec GmbH 201601– Managing Director) |
Managing Director |
SialoTec GmbH |
Germany |
| Preston, David (Boehringer Ingelheim 201112 CEO of Boehringer Ingelheim China) |
Chief Executive Officer (CEO) |
Boehringer Ingelheim (Group) |
China |
| Preti, Robert A. (Hitachi 201901 CEO Hitachi Chemical Advanced Therapeutics Solutions + General Manager RegMed business) |
Chief Executive Officer (CEO) |
Showa Denko (SDK) (Group) |
United States (USA) |
| Pretsell, Douglas (Northbank Communications Munich 200508) |
Public Relations Manager / Investor Relations Manager |
Instinctif Partners (Group) |
Germany |
| Price, Fredric D. (Chiasma 201302 CEO) |
Chief Executive Officer (CEO) |
Chiasma (Group) |
United States (USA) |
| Prieels, Jean-Paul (Themis Bioscience 201505– Board Member former SVP RnD at GSK Biologicals) |
Board member, non-executive |
Merck (US) (MSD) (Group) |
Austria |
| Prieschl-Grassauer, Eva (Marinomed Biotechnologie GmbH 201307 CSO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Marinomed Biotech AG (VSE: MARI) |
Austria |
| Prikazsky, Marc (CEVA 201203 CEO) |
Chief Executive Officer (CEO) |
CEVA (Group) |
France |
| Prince, William T. (Nabriva 200811– CMO before Surface Logix 200510 Chief Development Officer before GSK) |
Chief Medical Officer (CMO) |
Nabriva (Group) |
Austria |
| Princen, Marc (Takeda 201411– President Europe + Canada business unit before Merck + Schering-Plough) |
President/Director/Head Business Group/Unit/Division |
Takeda (Group) |
Switzerland |
| Priscoglio, Claudio (Cepheid 201304 Marketing Manager at Cepheid GmbH before BD) |
Sales Manager / Marketing Manager |
Danaher (Group) |
Germany |
| Pritchard, Randy (Roche 201211 VP Marketing at Roche Diagnostics Corp) |
Sales Manager / Marketing Manager |
Roche (Group) |
United States (USA) |
| Prokešová, Barbora (DataApex 201203) |
n. a. |
DataApex (CZ) |
Czech Republic |
| Proksch, Susanne (Spindiag 202005 Business Development + PR) |
Business Development Manager / Strategy Manager |
Spindiag GmbH |
Germany |
| Proll, Christiane (Numares 201612) |
Public Relations Manager / Investor Relations Manager |
Numares (Group) |
Germany |
| Proll, Günther (Biametrics GmbH 201105 Managing Director + Founder) |
Managing Director |
Biametrics GmbH |
Germany |
| Prüfer, Dirk (University of Munster 200808) |
n. a. |
University of Münster (Westfälische Wilhelms-Universität Münster) |
Germany |
| Przyborowski, Falko (Hansa Fine Chemicals 201212 Managing Director) |
Managing Director |
Hansa Fine Chemicals GmbH |
Germany |
| Przyborski, Stefan (Reinnervate 201207 CSO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
ReproCell (Group) |
United Kingdom (GB) |
| Przybylski, Michael (Univ Konstanz 2009 Professor Analytical Chemistry) |
Professor |
University of Constance (Universität Konstanz) |
Germany |
| Pröll, Florian (Biametrics GmbH 201105 Managing Director + Founder) |
Managing Director |
Biametrics GmbH |
Germany |
| Pröschel, Michael (Galenica 201102 Managing Director of Vifor Pharma Deutschland GmbH) |
Managing Director |
Vifor Pharma (Group) |
Germany |
| Pucci, Paolo (ArQule 201912 CEO before Bayer Schering Pharma 200701) |
Chief Executive Officer (CEO) |
Merck (US) (MSD) (Group) |
United States (USA) |
| Puchta, Josef (Helmholtz 201810 Commerical Board Director at DKFZ) |
Chief Commercial Officer (CCO) |
Helmholtz-Gemeinschaft (HGF) (Group) |
Germany |
| Pugh, John (Boehringer Ingelheim 201204 Director of Digital) |
Public Relations Manager / Investor Relations Manager |
Boehringer Ingelheim (Group) |
Germany |
| Puig de Dou, Joan (Kymos 202009 CEO) |
Chief Executive Officer (CEO) |
Kymos (Group) |
Spain (España) |
| Pul, Ümit (BRAIN 201410– Project Leader CRSIPR before Univ Düsseldorf) |
Research & Development Manager |
BRAIN (Group) |
Germany |
| Puls, Michael (evocatal 201002 Managing Director / CMO) |
Managing Director |
Advanced Enzyme Technologies (Advanced Enzymes) (Group) |
Germany |
| Pultar, Thomas (Biomeva GmbH 201104 Managing Director) |
Managing Director |
Asahi Glass (AGC) (Group) |
Germany |
| Punnamootil, Beena (Chimera Biotec 201402– Managing Director) |
Managing Director |
Kompass (Group) |
Germany |
| Purkarthofer, Thomas (VTU Technology 201412 Head Business Development) |
Business Development Manager / Strategy Manager |
KonValue (Group) |
Austria |
| Pusch, Wolfgang (Bruker Daltonics 201808 EVP Microbiology + Diagnostics) |
President/Director/Head Business Group/Unit/Division |
Bruker (Group) |
Germany |
| Puschmann, Till (CellGenix 202005 VP RnD + Business Development) |
Research & Development Manager |
CellGenix (Group) |
Germany |
| Putman, Jeff (Massa Investment AG 201906) |
Investment Manager |
Massa Investment AG |
Germany |
| Puttar, Thomas |
n. a. |
Asahi Glass (AGC) (Group) |
Germany |
| Putz, Pam (Informa 202003 Managing Director Europe of EBD Group) |
Managing Director |
Informa plc (Group) |
Germany |
| Puylaert, Kevin (Sophia Genetics 202002 VP Business Development) |
Business Development Manager / Strategy Manager |
Sophia Genetics (Group) |
Switzerland |
| Pühler, Alfred (Univ Bielefeld Prof) |
n. a. |
University of Bielefeld |
Germany |
| Pützer, Manfred (Omnilab (D) 200903 Managing Director) |
Managing Director |
Omnilab (DE) (Group) |
Germany |
| Pätz, Günther (Celares 201603 Managing Director) |
Managing Director |
Celares GmbH |
Germany |
| Pääbo, Svante (Max Planck 200805 MPI for Evolutionary Anthropology Leipzig) |
n. a. |
Max Planck Society for the Advancement of Science |
Germany |
| Pöhlchen, Martin (Sinfonie LS 201206– Managing Director before Revotar + SuppreMol + Pieris) |
Chief Executive Officer (CEO) |
Sinfonie Life Science Management GmbH |
Germany |
| Pöhlmann, Tobias (BianoScience GmbH 201203– Managing Director + Founder) |
Managing Director |
BianoScience GmbH |
Germany |
| Pöpping, Bert (FOCOS GbR 201703– Co-Owner before Mérieux NutriSciences + GROFOR + Eurofins) |
Research & Development Manager |
FOCOS GbR (FOCOS Food Consulting) – Dr. Bert Pöpping + Dr. Carmen Diaz-Amigo |
Germany |
| Pörtner, Ralf (TU Hamburg-Harburg 201109 Professor) |
Professor |
Technical University Hamburg-Harburg (TUHH) |
Germany |
| Pötting, Sierk (BioNTech 201409– CFO before Sandoz Inc/Novartis + McKinsey) |
Chief Financial Officer (CFO) |
BioNTech (Group) |
Germany |
| Pötz, Oliver (Signatope GmbH 201608– Managing Director + Co-Founder before Univ Tübingen Researcher at NMI) |
Researcher (university / research institute) |
Signatope GmbH |
Germany |
| Pötzsch, Jörg (RNAx GmbH 200604 CEO) |
Chief Executive Officer (CEO) |
RNAx GmbH |
Germany |
| Quandt, Achim (Qiagen 200905 Senior Global Product Manager) |
Product Manager (personnel) |
Qiagen (Group) |
Germany |
| Quennet-Thielen, Cornelia (Germany (govt) 200808 Secretary of State BMBF) |
n. a. |
Germany (govt) |
Germany |
| Questier, Bernard (Evotec OAI 200310–200408) |
n. a. |
Evotec (Group) |
Germany |
| Quinn, Dan (Ten Bridge Communications 201612 CEO + Co-Founder before Feinstein Kean Healthcare + Genzmye) |
Chief Executive Officer (CEO) |
Ten Bridge Communications (US) |
United States (USA) |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo-2019.png){kind=logo}
1 2 3 ... 50 51 52 ... 73 74 75 
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20111029-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
